AbCellera Biologics (ABCL) PT Raised to $11 at Cantor Fitzgerald Post Q1 Print, Trial Data
Tweet Send to a Friend
(Updated - May 12, 2026 9:27 AM EDT)
Cantor Fitzgerald analyst Steve Seedhouse raised the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Cantor Fitzgerald analyst Steve Seedhouse raised the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
